51. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation
- Author
-
Takeshi Tada, Masato Murakami, Nobuhiro Nishii, Kazufumi Nakamura, Yoshiki Hata, Kunihisa Kohno, Keiko Ohta-Ogo, Koji Nakagawa, Masamichi Tanaka, Hiroshi Morita, Kengo Fukushima Kusano, Aya Miura, Mamoru Ouchida, Hiroshi Ito, Kenji Shimizu, Daiji Miura, Tohru Ohe, Chikao Yutani, and Satoshi Nagase
- Subjects
Male ,congenital, hereditary, and neonatal diseases and abnormalities ,medicine.medical_specialty ,Antigens, Differentiation, Myelomonocytic ,Muscle Proteins ,medicine.disease_cause ,Sodium Channels ,NAV1.5 Voltage-Gated Sodium Channel ,Pathology and Forensic Medicine ,Electrocardiography ,Antigens, CD ,Internal medicine ,Humans ,Medicine ,cardiovascular diseases ,Brugada Syndrome ,DNA Primers ,Brugada syndrome ,Aldehydes ,Base Sequence ,medicine.diagnostic_test ,business.industry ,CD68 ,Myocardium ,Cardiac arrhythmia ,General Medicine ,Middle Aged ,medicine.disease ,Immunohistochemistry ,Pathophysiology ,Oxidative Stress ,Mutation ,Ventricular Fibrillation ,Mutation (genetic algorithm) ,Ventricular fibrillation ,cardiovascular system ,Cardiology ,Leukocyte Common Antigens ,Female ,Lipid Peroxidation ,Cardiology and Cardiovascular Medicine ,business ,Oxidative stress ,Endocardium - Abstract
Brugada syndrome is a disease known to cause ventricular fibrillation with a structurally normal heart and is linked to SCN5A gene mutation. However, the mechanism by which ventricular fibrillation develops in cases of Brugada-type electrocardiogram without SCN5A mutation has remained unclear. Recently, oxidative stress has been implicated in the pathophysiology of cardiac arrhythmia. We also investigated oxidative stress levels in the myocardia of patients with Brugada-type electrocardiogram.Endomyocardial biopsy samples were obtained from 68 patients with Brugada-type electrocardiogram (66 males and two females). We performed histological and immunohistochemical analyses for CD45, CD68, and 4-hydroxy-2-nonenal-modified protein, which is a major lipid peroxidation product.SCN5A mutation was detected in 14 patients. Ventricular fibrillation was documented in three patients with SCN5A mutation and in 11 without SCN5A mutation. In patients with SCN5A mutation, 4-hydroxy-2-nonenal-modified protein-positive area was not significantly different between the documented ventricular fibrillation (VF) group (VF+ group) and the group without documented VF (VF- group). However, in patients without SCN5A, the area was significantly larger in the VF+ group than that in the VF- group (P.05). All other parameters (fibrosis area, CD45, and CD68) were not different between the VF+ and VF- group in both SCN5A+ and SCN5A- patients.Oxidative stress is elevated in the myocardium of patients with Brugada-type electrocardiogram who have VF episodes and do not have SCN5A gene mutations. Oxidative stress may be associated with the occurrence of VF in patients with Brugada-type electrocardiogram without SCN5A mutation.
- Published
- 2011
- Full Text
- View/download PDF